免疫代谢疾病和治疗方法:通过炎症体信号传递的分子机制
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Woosuk University, Wanju, 55338, Republic of Korea. hanjh5621@woosuk.ac.kr.
Cell communication and signaling : CCS
|August 20, 2025
概括
炎症酶是炎症的关键调节体, 越来越多地与肥胖和糖尿病等慢性代谢疾病有关. 针对炎症体路径提供了一种有前途的策略来对抗这些疾病.
科学领域:
- 免疫学
- 代谢疾病
- 细胞生物学
背景情况:
- 炎症反应对防御至关重要, 但长期激活会导致代谢疾病.
- 炎症酶,特别是NLRP3,是感知危险信号并激活IL-1β和IL-18等促炎细胞因子的中央调节器.
- 不调节的炎症细胞活动有助于免疫代谢疾病,如肥胖,糖尿病,动脉样硬化和肉症.
研究的目的:
- 提供有关炎症生物学的最新概述.
- 确定炎症体在四种主要免疫代谢疾病中的作用.
- 讨论针对炎症细胞通路的最新进展.
主要方法:
- 关于炎症体生物学及其在代谢疾病中的作用的最新科学文献的综述.
- 对研究炎症酶激活与肥胖,糖尿病,动脉样硬化和肉症等特定疾病之间的联系的分析.
- 针对炎症体通路的治疗策略的最新研究综合.
主要成果:
- 持续的炎症酶激活,特别是NLRP3,与慢性代谢疾病的发病有关.
- 异常的炎症酶活动会加剧胰岛素抵抗,脂质失调,肌肉消耗和血管损伤.
- 针对炎症体信号提供了一个可行的治疗途径来缓解炎症和代谢功能障碍.
结论:
- 炎症体是关键的调解器,可以将免疫功能障碍与代谢失衡联系起来.
- 了解炎症组合到代谢疾病的分子场景提供了新的治疗点.
- 调节炎细胞通路有可能治疗慢性炎症和代谢障碍.
相关概念视频
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Autoimmune Disorders
671
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
671
Inflammatory Response
7.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
7.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
267
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
267
Inflammatory Bowel Disease IV: Pharmacological Management
189
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
189
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
231
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
231


